A healthcare innovation venture capital firm, CerraCap Ventures, has invested in Acorai, a cardiovascular health technology company. The investment will support the development of Acorai’s Acorai Heart Monitor (AHM), a device designed to measure intracardiac pressures non-invasively, providing accurate and reliable data for heart failure management. With funding from CerraCap Ventures, Acorai plans to conduct global clinical studies to gain FDA approval and launch AHM in the market. This investment reflects CerraCap’s confidence in Acorai’s approach to enhancing patient outcomes and its commitment to transforming cardiovascular health.
CerraCap Ventures Fuels Acorai, Propelling Revolutionary Heart Failure Management
Latest from Blog
VCFA Group Closes $1225M Venture Partners VII Fund
TLDR: VCFA Group closed VCFA Venture Partners VII fund with $122.5 million in commitments Transition marks continuation of VCFA’s pioneering legacy in the secondary private equity space VCFA Group, a pioneer in
VCFA Group’s Venture Partners VII Fund Raises $1225 Million
TLDR: VCFA Group closed its latest fund, VCFA Venture Partners VII, with $122.5 million in commitments. The fund focuses on smaller and more complex purchases of later-stage venture capital and growth equity
Revolutionizing Payments: $20M Raised for Stablecoin Network Development
TLDR: 1Money has raised over $20 million in seed funding to develop a stablecoin payments network. The network aims to offer instant transaction confirmation, low-cost fees, multicurrency support, compliance mechanisms, and scalability.
Top AI Trends and Startups Shaping 2025 and Beyond
“`html TLDR: Israel is excelling in applicative and vertical AI, focusing on practical solutions in cybersecurity, healthcare, and defense rather than competing with tech giants in foundational AI models. Five key AI
Sand Hill Road: Steve Vassallo’s Early Investment Edge at Foundation Capital
“`html TLDR: Steve Vassallo, a general partner at Foundation Capital, focuses on early-stage investments, often being the first institutional investor for startups. He emphasizes the importance of owning a significant stake in